Articles Art of Medicine Aug 2019 Selected Drawings From Corpus Delicti Tracy Meyer This collection of drawings offers a visual exploration of compassion, respect, and dignity in clinical relationships and encounters. AMA J Ethics. 2019;21(8):E701-708. doi: 10.1001/amajethics.2019.701. From the Editor in Chief Aug 2019 Ethics of Prescription Medication Access, Innovation, and Prescribing Audiey C. Kao, MD, PhD Medications now challenge clinicians to consider market influences such as pharmaceutical manufacturing, pricing strategies, and patients’ resources. AMA J Ethics. 2019;21(8):E627-629. doi: 10.1001/amajethics.2019.627. Art of Medicine Aug 2019 If _____ Is Right for You Alana Noelle Snyder This mixed media collage explores pharmaceutical companies’ influence on the daily lives of American citizens and on patient-physician relationships. AMA J Ethics. 2019;21(8):E697-698. doi: 10.1001/amajethics.2019.697. Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559. Case and Commentary Jul 2019 When There’s No One to Whom an Error Can Be Disclosed, How Should an Error Be Handled? Ryan G. Chiu When a patient is incompetent and unrepresented, alternative strategies must be implemented to document and try to rectify an error. AMA J Ethics. 2019;21(7):E553-558. doi: 10.1001/amajethics.2019.553. Health Law Jul 2019 Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making Lisa K. Anderson-Shaw, DrPH, MA, MSN, ANP-BC A UPAC is an alternative to engaging a guardianship court appointment process or to using physicians or ethics committees as decision makers. AMA J Ethics. 2019;21(7):E594-599. doi: 10.1001/amajethics.2019.594. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. Health Law Jul 2019 Five Things Clinicians Should Know When Caring for Unrepresented Patients Thaddeus Mason Pope, JD, PhD Despite challenges of decision making for unrepresented patients, few laws or policy statements offer solutions. This article offers 5 key things to do. AMA J Ethics. 2019;21(7):E582-586. doi: 10.1001/amajethics.2019.582. Pagination First page « First Previous page ‹ Prev … Page 95 Page 96 Page 97 Page 98 Current page 99 Page 100 Page 101 Page 102 Page 103 … Next page Next › Last page Last »
Art of Medicine Aug 2019 Selected Drawings From Corpus Delicti Tracy Meyer This collection of drawings offers a visual exploration of compassion, respect, and dignity in clinical relationships and encounters. AMA J Ethics. 2019;21(8):E701-708. doi: 10.1001/amajethics.2019.701.
From the Editor in Chief Aug 2019 Ethics of Prescription Medication Access, Innovation, and Prescribing Audiey C. Kao, MD, PhD Medications now challenge clinicians to consider market influences such as pharmaceutical manufacturing, pricing strategies, and patients’ resources. AMA J Ethics. 2019;21(8):E627-629. doi: 10.1001/amajethics.2019.627.
Art of Medicine Aug 2019 If _____ Is Right for You Alana Noelle Snyder This mixed media collage explores pharmaceutical companies’ influence on the daily lives of American citizens and on patient-physician relationships. AMA J Ethics. 2019;21(8):E697-698. doi: 10.1001/amajethics.2019.697.
Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559.
Case and Commentary Jul 2019 When There’s No One to Whom an Error Can Be Disclosed, How Should an Error Be Handled? Ryan G. Chiu When a patient is incompetent and unrepresented, alternative strategies must be implemented to document and try to rectify an error. AMA J Ethics. 2019;21(7):E553-558. doi: 10.1001/amajethics.2019.553.
Health Law Jul 2019 Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making Lisa K. Anderson-Shaw, DrPH, MA, MSN, ANP-BC A UPAC is an alternative to engaging a guardianship court appointment process or to using physicians or ethics committees as decision makers. AMA J Ethics. 2019;21(7):E594-599. doi: 10.1001/amajethics.2019.594.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.
Health Law Jul 2019 Five Things Clinicians Should Know When Caring for Unrepresented Patients Thaddeus Mason Pope, JD, PhD Despite challenges of decision making for unrepresented patients, few laws or policy statements offer solutions. This article offers 5 key things to do. AMA J Ethics. 2019;21(7):E582-586. doi: 10.1001/amajethics.2019.582.
